Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
<< View more issues
Special Issues - Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW
Articles
"Fast and Furious" Development of Novel Approaches Changes Face of Myeloma Treatment
BCMA-Targeting Strategies Transform Multiple Myeloma Treatment
BCMA Antibody-Drug Conjugate Belantamab Mafodotin Succeeds in Phase II Myeloma Trial
Intriguing BCMA-Targeted Therapies Move Through Myeloma Pipeline
Myriad Modalities Advance Multiple Myeloma Paradigm
Novel Therapies Surge Forward in Relapsed/Refractory Multiple Myeloma
Addressing Belantamab Mafodotin-Related Corneal Events in Myeloma is Key to Continuing Treatment
Videos
Dr. Avigan on BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma
Dr. Popat on the DREAMM-1 Trial in Relapsed/Refractory Multiple Myeloma
Dr. Richardson on Preliminary Data With Belantamab Mafodotin in Multiple Myeloma
Dr. Usmani on DREAMM Trials in Multiple Myeloma
OncLive News Network On Location: ASH 2019 Day 3
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe